Lingeng Lu
Overview
Explore the profile of Lingeng Lu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
202
Citations
4827
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Li N, Yao S, Yu G, Lu L, Wang Z
Nucleic Acids Res
. 2023 Oct;
52(D1):D345-D350.
PMID: 37811890
tRFtarget 1.0 (http://trftarget.net/) is a platform consolidating both computationally predicted and experimentally validated binding sites between transfer RNA-derived fragments (tRFs) and target genes (or transcripts) across multiple organisms. Here, we...
22.
Wang Y, Lu L, Ling C, Zhang P, Han R
Nutrients
. 2023 Sep;
15(18).
PMID: 37764768
Breast cancer (BC) is a lethal malignancy with high morbidity and mortality but lacks effective treatments thus far. Despite the introduction of immune checkpoint inhibitors (ICIs) (including PD-1/PD-L1 inhibitors), durable...
23.
Han R, Ling C, Wang Y, Lu L
Cancer Cell Int
. 2023 Sep;
23(1):203.
PMID: 37716965
Hepatocellular carcinoma (HCC) is a malignancy with high morbidity and mortality but lacks effective treatments thus far. Although the emergence of immune checkpoint inhibitors in recent years has shed light...
24.
Frias-Gomez J, Alemany L, Benavente Y, Clarke M, de Francisco J, De Vivo I, et al.
Sleep Med Rev
. 2023 Sep;
72:101848.
PMID: 37716022
Data on the role of circadian related factors in the etiology of endometrial cancer are scarce. We collected individual data on night shift work or daily sleep duration from 7,207...
25.
Fu R, Sun K, Wang X, Liu B, Wang T, Morze J, et al.
Lancet Reg Health West Pac
. 2023 Sep;
37:100799.
PMID: 37693879
Background: The systematic comparison of cancer survival between China and the USA is rare. Here we aimed to assess the magnitude of survival disparities and disentangle the impact of the...
26.
Zeng H, Xu M, Xie Y, Nawrocki S, Morze J, Ran X, et al.
EClinicalMedicine
. 2023 Aug;
62:102138.
PMID: 37593228
Background: Racial/ethnic disparities in prostate cancer are reported in the United States (US). However, long-term trends and contributors of racial/ethnic disparities in all-cause and cause-specific death among patients with prostate...
27.
Yao Y, Yao J, Chen S, Zhang X, Meng H, Li Y, et al.
Behav Sci (Basel)
. 2023 Jul;
13(7).
PMID: 37503999
Background: To explore the association between the self-reported health status, depressive tendency, psychological capital, and self-acceptance of college students in China during the COVID-19 pandemic. Methods: Using the online survey...
28.
Cartmel B, Li F, Zhou Y, Gottlieb L, Lu L, Mszar R, et al.
Cancer Med
. 2023 Jun;
12(14):15492-15503.
PMID: 37269192
Background: In randomized trials in women with breast cancer, exercise has been shown to have beneficial effects on cancer-related circulating biomarkers that may impact survival. Such studies are lacking for...
29.
Lu L, Zhang Q, Shen X, Zhen P, Marin A, Garcia-Milian R, et al.
bioRxiv
. 2023 May;
PMID: 37205388
The nutrient status of the tumor microenvironment has major impacts on cell growth. Under nutrient depletion, asparagine synthetase (ASNS)-mediated asparagine production increases to sustain cell survival. G protein-coupled estrogen receptor-1...
30.
Han R, Li J, Hony J, Xiao Z, Wang J, Yao M, et al.
Front Immunol
. 2023 Apr;
14:1052657.
PMID: 37006233
Hepatocellular carcinoma (HCC) is a lethal malignancy with a lack of effective treatments particularly for the disease at an advanced stage. Even though immune checkpoint inhibitors (ICIs) have made great...